Cefotaxime MIP

Medicinal product

(Invented) name

Cefotaxime MIP

Active substance (s)

Cefotaksimas

Strength

2 g

Pharmaceutical form

milteliai injekciniam ar infuziniam tirpalui

Route (s) of administration

leisti į veną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

J01DD01, Cefotaxime

Marketing authorisation holder

MIP Pharma GmbH, Vokietija

Date of authorisation

2013-08-13

Date of renewal

2018-09-27

Documents

3362 Pakuotės lapelis 2024 08 18.docx

3362 Cefotaxime MIP PCS PL 2024 08 18.docx

Stage

Perregistruotas

Controlled?

No

Controlled substance type

Legal basis

10(1)

Procedure number

DK/H/2158/002/DC

Marketing authorisation procedure

Decentralizuota procedūra

Qualitative and quantitative composition

1 flakone yra	1 vnt.
Cefotaksimas	2 g

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
51256	65149	1065149	flakonas	N1		Receptinis	LT/1/13/3362/004	Netiekiama	-	-	No	-	-
57019	71127	1071127	flakonas	N5		Receptinis	LT/1/13/3362/005	Netiekiama	-	-	No	-	-
57020	71128	1071128	flakonas	N10		Receptinis	LT/1/13/3362/006	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2018-09-27	Perregistruotas
2013-08-13	Registruotas